DOI QR코드

DOI QR Code

Recurrent Prosthetic Mitral Valve Dehiscence due to Infective Endocarditis: Discussion of Possible Causes

  • Ercan, Suleyman (Department of Cardiology, Gaziantep University School of Medicine) ;
  • Altunbas, Gokhan (Department of Cardiology, Kilis State Hospital) ;
  • Deniz, Hayati (Department of Cardiovascular Surgery, Gaziantep University School of Medicine) ;
  • Gokaslan, Gokhan (Department of Cardiovascular Surgery, Gaziantep University School of Medicine) ;
  • Bosnak, Vuslat (Department of Infectious Diseases, Gaziantep University School of Medicine) ;
  • Kaplan, Mehmet (Department of Cardiology, Gaziantep University School of Medicine) ;
  • Davutoglu, Vedat (Department of Cardiology, Gaziantep University School of Medicine)
  • Received : 2012.11.14
  • Accepted : 2013.01.24
  • Published : 2013.08.05

Abstract

Prosthetic valves are being widely used in the treatment of heart valve disease. Prosthetic valve endocarditis (PVE) is one of the most catastrophic complications seen in these patients. In particular, prosthetic valve dehiscence can lead to acute decompensation, pulmonary edema, and cardiogenic shock. Here, we discuss the medical management of late PVE in a patient with a prior history of late and redo early PVE and recurrent dehiscence. According to the present case, we can summarize the learning points as follows. A prior history of infective endocarditis increases the risk of relapse or recurrence, and these patients should be evaluated very cautiously to prevent late complications. Adequate debridement of infected material is of paramount importance to prevent relapse. A history of dehiscence is associated with increased risk of relapse and recurrent dehiscence.

Keywords

References

  1. Baddour LM, Wilson WR, Bayer AS, et al. Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America. Circulation 2005; 111:e394-434. https://doi.org/10.1161/CIRCULATIONAHA.105.165564
  2. Oakley CM, Hall RJ. Endocarditis: problems--patients being treated for endocarditis and not doing well. Heart 2001;85: 470-4. https://doi.org/10.1136/heart.85.4.470
  3. Habib G, Tribouilloy C, Thuny F, et al. Prosthetic valve endocarditis: who needs surgery?: a multicentre study of 104 cases. Heart 2005;91:954-9. https://doi.org/10.1136/hrt.2004.046177
  4. Rostagno C, Carone E, Rossi A, Gensini GF, Stefano PL. Surgical treatment in active infective endocarditis: results of a four-year experience. ISRN Cardiol 2011;2011:492543.
  5. Mansur AJ, Dal Bo CM, Fukushima JT, Issa VS, Grinberg M, Pomerantzeff PM. Relapses, recurrences, valve replacements, and mortality during the long-term follow-up after infective endocarditis. Am Heart J 2001;141:78-86. https://doi.org/10.1067/mhj.2001.111952
  6. Newton S, Hunter S. What type of valve replacement should be used in patients with endocarditis? Interact Cardiovasc Thorac Surg 2010;11:784-8. https://doi.org/10.1510/icvts.2010.234450
  7. Chu VH, Sexton DJ, Cabell CH, et al. Repeat infective endocarditis: differentiating relapse from reinfection. Clin Infect Dis 2005;41:406-9. https://doi.org/10.1086/431590

Cited by

  1. Percutaneous Closure of Paravalvular Leak from a Rocking Mitral Valve in a 74-Year-Old Man at High Surgical Risk vol.47, pp.2, 2013, https://doi.org/10.14503/thij-18-6626